Spyre Therapeutics Appoints Kate Tansey Chevlen as Chief Commercial Officer
I'm PortAI, I can summarize articles.
Spyre Therapeutics Inc. has appointed Kate Tansey Chevlen as Chief Commercial Officer. She previously held the position of VP, Global Marketing Head for Immunology and Inflammation at Amgen. This announcement is part of the company's ongoing efforts to strengthen its leadership team.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments